Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau Oligomers Neurotoxicity
Grażyna Niewiadomska, Wiktor Niewiadomski, Marta Steczkowska, et al.
Life (2021) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Tau-targeting therapies for Alzheimer disease: current status and future directions
Erin E. Congdon, Changyi Ji, Amber M. Tetlow, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 715-736
Closed Access | Times Cited: 128
Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies
Galina Limorenko, Hilal A. Lashuel
Chemical Society Reviews (2021) Vol. 51, Iss. 2, pp. 513-565
Open Access | Times Cited: 114
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Prashanth Gowda, P. Hemachandra Reddy, Subodh Kumar
Ageing Research Reviews (2021) Vol. 73, pp. 101529-101529
Open Access | Times Cited: 107
Tau Oligomer–Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease
Raquel N. Taddei, Romain Perbet, Anastasie Maté de Gérando, et al.
JAMA Neurology (2023) Vol. 80, Iss. 11, pp. 1209-1209
Open Access | Times Cited: 49
Inflammatory aspects of Alzheimer’s disease
Pablo Botella Lucena, Michael T. Heneka
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Closed Access | Times Cited: 26
Similar brain proteomic signatures in Alzheimer’s disease and epilepsy
Dominique Leitner, Geoffrey Pires, Tomas Kavanagh, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 19
Tau as a Biomarker of Neurodegeneration
Sarah Holper, Rosie Watson, Nawaf Yassi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7307-7307
Open Access | Times Cited: 59
The Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Haiqiong Ye, Yue Han, Ping Li, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 8, pp. 1557-1571
Closed Access | Times Cited: 44
Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin
Drug Discovery Today (2023) Vol. 28, Iss. 3, pp. 103487-103487
Open Access | Times Cited: 42
Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies
Sagar Gaikwad, Sudipta Senapati, Md. Anzarul Haque, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 709-727
Open Access | Times Cited: 32
Glucocorticoid-driven mitochondrial damage stimulates Tau pathology
Fang Du, Qing Yu, Russell H. Swerdlow, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 4378-4394
Open Access | Times Cited: 26
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
Huiting Zheng, Huimin Sun, Qixu Cai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4969-4969
Open Access | Times Cited: 12
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
Sriram Balusu, Bart De Strooper
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 11
Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice
Sagar Gaikwad, Nicha Puangmalai, Minal Sonawane, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Closed Access | Times Cited: 11
Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status
Haoshen Shi, Nazanin Mirzaei, Yosef Koronyo, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 11
Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress
Lindsey D. Goodman, Isha Ralhan, Xin Li, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 10, pp. 1918-1933
Closed Access | Times Cited: 9
Cognitive resilience in Alzheimer’s disease: mechanism and potential clinical intervention
Bin Jia, Yun Xu, Xiaolei Zhu
Ageing Research Reviews (2025) Vol. 106, pp. 102711-102711
Closed Access | Times Cited: 1
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Lisha Wang, Sooram Banesh, Rajnish Kumar, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Phosphorylation of Tau R2 Repeat Destabilizes Its Binding to Microtubules: A Molecular Dynamics Simulation Study
Viet Hoang Man, Xibing He, Jie Gao, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 458-467
Open Access | Times Cited: 20
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy
Tony Eteläinen, M. Catarina Silva, Johanna Uhari‐Väänänen, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 691
Closed Access | Times Cited: 18
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Xingyu Zhang, Jiangyu Wang, Zhentao Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Modulation of Tau Pathology in Alzheimer’s Disease by Dietary Bioactive Compounds
Huahua Shi, Yan Zhao
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 831-831
Open Access | Times Cited: 6
Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer’s-like Tauopathy Mouse Model
Maciej Zadrożny, Patrycja Drapich, Anna Gasiorowska-Bien, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 642-642
Open Access | Times Cited: 6
Oligomeric Tau-induced oxidative damage and functional alterations in cerebral endothelial cells: Role of RhoA/ROCK signaling pathway
Faruk Hossen, Grace Y. Sun, James C. Lee
Free Radical Biology and Medicine (2024) Vol. 221, pp. 261-272
Open Access | Times Cited: 6
Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease
Somayra Mamsa, Bruno P. Meloni
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top